Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
2.550
+0.230 (9.91%)
At close: Apr 23, 2025, 4:00 PM
2.530
-0.020 (-0.78%)
After-hours: Apr 23, 2025, 5:40 PM EDT
Regulus Therapeutics Market Cap
Regulus Therapeutics has a market cap or net worth of $168.92 million as of April 23, 2025. Its market cap has decreased by -3.36% in one year.
Market Cap
168.92M
Enterprise Value
94.20M
1-Year Change
-3.36%
Ranking
Category
Stock Price
$2.55
Market Cap Chart
Since December 31, 2012, Regulus Therapeutics's market cap has decreased from $225.70M to $168.92M, a decrease of -25.16%. That is a compound annual growth rate of -2.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 168.90M | 63.19% |
| Dec 31, 2024 | 103.50M | 299.61% |
| Dec 29, 2023 | 25.90M | 12.12% |
| Dec 30, 2022 | 23.10M | -15.69% |
| Dec 31, 2021 | 27.40M | -48.20% |
| Dec 31, 2020 | 52.90M | 184.41% |
| Dec 31, 2019 | 18.60M | 129.63% |
| Dec 31, 2018 | 8.10M | -92.51% |
| Dec 29, 2017 | 108.10M | -9.24% |
| Dec 30, 2016 | 119.10M | -73.90% |
| Dec 31, 2015 | 456.40M | -41.46% |
| Dec 31, 2014 | 779.60M | 152.54% |
| Dec 31, 2013 | 308.70M | 36.77% |
| Dec 31, 2012 | 225.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 754.27B |
| UnitedHealth Group | 415.38B |
| Johnson & Johnson | 379.48B |
| AbbVie | 306.02B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 227.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |